Fig. 3From: A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expressionForest plot of the association of EpCAM immunoexpression with the clinicopathological features of patients with prostate cancerBack to article page